Elixinol Global in the News

    Stockhead: Reports that a third of US companies selling hemp CBD products are about to disappear, and that’s actually great news!  
    The Motley Fool: Reports that Elixinol Global’s share price has rocketed 90% higher so far this year and is a red hot option within the industrial hemp and medicinal cannabis industries.  
    Seeking Alpha: Reports that Elixinol's attractive valuation and large addressable market make it an investment worth considering  
    Food & Drinks Business: Reports on licensing delays due to an overworked and understaffed Office of Drug Control  
    “Elixinol pivots to pet pot treats, nabs 25pc stake in US hemp manufacturer” reports Stockhead  
    Finance News Network reports “Elixinol Global to buy into pet cannabis company”  
    Is Elixinol Global the Fastest Growing Hemp/CBD Producer? I Streetwise Reports  
    Elixinol Global Signalling Significant Bullish Breakout I Insider Financial  
    Women are naturally drawn to medical marijuana, says Elixinol Global MD I Stockhead  
    Will Pot Stocks Live Up to Their Promise? I The Bull  
    Elixinol Global: Seeing High Profits From Diverse Investments I The Green Fund  
    "The Pot Seat: Elixinol’s Paul Benhaim is spending to stay on top” reports Stockhead  
    Elixinol Global Makes Hemp Play in $215 Million Vegan Food Sector | The Green Fund  
    Elixinol Global FY2018 full year results investor conference call recording  
    Stockhead reports that Elixinol Global (ASX:EXL) more than doubled its revenue in 2018 and expects continued financial growth this year.  
    Your Money interviews EXL CEO Paul Benhaim about the company’s 2018 financial results and its plans for further growth.  
    New Cannabis Ventures reports on Elixinol Global’s FY2018 results.  
    Elixinol Global is listed in Small Caps' top 10 ASX IPOs in 2018.  
    Insider Financial reports on Elixinol Global's international strategy and continued strong growth  
    Finfeed reports on Elixinol Global's recent share price increase and the company's strong financial position in the global market  
    Stockhead reports on Elixinol Global’s growth opportunities in the US  
    ABC News reveals Elixinol Global was one of the best performing stocks to debut on the ASX in 2018  
    AFR reports on Elixinol Global’s success in 2018  
    Wall Street Reporter interviews Elixinol Global CEO Paul Benhaim about EXL's progress in the CBD and hemp consumer products and foods markets  
    Sydney Morning Herald looks at the rise of the CBD industry, as well as the recent passage of the US Farm Bill and the positive impact this is having on Elixinol Global  
    Stockhead interviews Elixinol Global CEO Paul Benhaim about Australia’s medicinal cannabis regulations  
    Small Caps says Elixinol Global marks first shipment to New Zealand  
    Stockhead reports on Elixinol Global crossing the Tasman into New Zealand  
    Finance News Network reports on Elixinol launching in New Zealand  
    The Green Fund lists Elixinol Global in its Top 3 Hemp Stocks for 2019  
    The Motley Fool reports that Elixinol Global is up 68% in 2018  
    The Fly talks to Elixinol Global’s CEO about the company, competition and hemp legalisation  
    Streetwise Reports reveals 15 reasons why Elixinol Global should be in your portfolio  
    CommSec TV: Executive Series interview with Elixinol Global’s CEO, Paul Benhaim discussing the pending US Farm Bill with Tom Piotrowski  
    Stockhead reports on pending US Farm Bill and talks to Elixinol Global’s Paul Benhaim  
    Elixinol Global set to benefit from nearing of US Farm Bill legislation  
    US Farm Bill set to legalise and commercialise industrial hemp  
    Hemp’s cognitive help: Elixinol’s supplements finding favour amongst Japanese consumers  
    News.com.au – Cannabis expert says we’re just scratching the surface in unlocking the plant’s potential  
    Business News Australia reports on Elixinol Global’s strong 3Q FY2018 results  
    New Cannabis Ventures reports on Elixinol Global’s 3Q FY2018 revenue growth  
    CFN Media Interviews Elixinol’s Director of Business Development, Ruben Gonzales  
    The Sydney Morning Herald reports on the ‘hemp boom’ in Australia and features an interview with EXL CEO Paul Benhaim  
    New Cannabis Ventures says Elixinol Global raises A$40 million to expand global CBD operations  
    CommSec TV: Executive Series interview with Elixinol Global’s CEO, Paul Benhaim  
    Elixinol Global is the sleeping giant of the Hemp Market reports The Green Fund  
    Elixinol Global featured in Biotech Daily’s weekly column ‘Dr Boreham’s Crucible’  
    “Hemp is hot” and Elixinol Global is positioned to take full advantage  
    Elixinol Global 'only company in the sector to list a profit'  
    Stockhead reports Elixinol Global is one of the world’s top cannabis companies  
    Elixinol Global listed as the only ASX cannabis stock making a profit following its 1H FY2018 results  
    Sky News reports on Elixinol Global’s strong financial results  
    Elixinol Global doubles in size since ASX debut reports Small Caps